Clinical features of Friedreich's ataxia: classical and atypical phenotypes

Clinical features of Friedreich's ataxia: classical and atypical phenotypes. Michael H. Parkinson, Sylvia Boesch, Wolfgang Nachbauer, Caterina Mariotti, Paola Giunti. J. Neurochem.(2013) 126 (Suppl. 1), 103–117. DOI: 10.1111/jnc.12317

FULL TEXT PDF

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia. Joel M. Gottesfeld, James R. Rusche and Massimo Pandolfo. J. Neurochem.(2013) 126 (Suppl. 1), 147–154. DOI: 10.1111/jnc.12302

FULL TEXT PDF

Cardiomyopathy of Friedreich Ataxia

Cardiomyopathy of Friedreich Ataxia Frank Weidemann, Stefan Störk, Dan Liu, Kai Hu, Sebastian Herrmann, Georg Ertl and Markus Niemann. J. Neurochem.(2013) 126 (Suppl. 1), 88–93. DOI: 10.1111/jnc.12217

FULL TEXT PDF

Erythropoietin in Friedreich ataxia

Erythropoietin in Friedreich ataxia. Caterina Mariotti, Wolfgang Nachbauer, Marta Panzeri, Werner Poewe, Franco Taroni and Sylvia Boesch. J. Neurochem.(2013) 126 (Suppl. 1), 80–87. DOI: 10.1111/jnc.12301

FULL TEXT PDF

Animal and cellular models of Friedreich ataxia

Animal and cellular models of Friedreich ataxia. Morgane Perdomini, Aurore Hick, Hélène Puccio and Mark A. Pook. J. Neurochem.(2013) 126 (Suppl. 1), 65–79. DOI: 10.1111/jnc.12219

FULL TEXT PDF

Frataxin: a protein in search for a function

Frataxin: a protein in search for a function. Annalisa Pastore and Helene Puccio; J. Neurochem.(2013) 126 (Suppl. 1), 43–52. DOI: 10.1111/jnc.12220

FULL TEXT PDF

Gene regulation and epigenetics in Friedreich's ataxia

Gene regulation and epigenetics in Friedreich's ataxia. Cihangir Yandim, Theona Natisvili and Richard Festenstein. J. Neurochem.(2013) 126 (Suppl. 1), 21–42. DOI: 10.1111/jnc.12254

FULL TEXT PDF

Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge

Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge. Pierre Vankan; J. Neurochem.(2013) 126 (Suppl. 1), 11–20. DOI: 10.1111/jnc.12215

FULL TEXT PDF

Nikolaus Friedreich and degenerative atrophy of the dorsal columns of the spinal cord

Nikolaus Friedreich and degenerative atrophy of the dorsal columns of the spinal cord. Arnulf H. Koeppen; J. Neurochem.(2013) 126 (Suppl. 1), 4–10. DOI: 10.1111/jnc.12218

FULL TEXT PDF

Deferiprone for the treatment of Friedreich's ataxia

Deferiprone for the treatment of Friedreich's ataxia. Massimo Pandolfo1, Laura Hausmann. J. Neurochem.(2013) 126 (Suppl. 1), 142–146. DOI: 10.1111/jnc.12300

FULL TEXT PDF

Co-enzyme Q10 and idebenone use in Friedreich's ataxia

Co-enzyme Q10 and idebenone use in Friedreich's ataxia. Michael H Parkinson, Jörg B. Schulz, Paola Giunti1; J. Neurochem.(2013) 126 (Suppl. 1), 125–141. DOI: 10.1111/jnc.12322

FULL TEXT PDF

Diabetes in Friedreich Ataxia

Diabetes in Friedreich Ataxia. Miriam Cnop, Hindrik Mulder, Mariana Igoillo-Esteve. J. Neurochem.(2013) 126 (Suppl. 1), 94–102. DOI: 10.1111/jnc.12216

FULL TEXT PDF

Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales

Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales; Katrin Bürk Stefanie R. Schulz, Jörg B. Schulz; J. Neurochem.(2013) 126 (Suppl. 1),118–124. DOI: 10.1111/jnc.12318

FULL TEXT PDF

Mitochondrial pathophysiology in Friedreich's ataxia

Mitochondrial pathophysiology in Friedreich's ataxia Pilar González-Cabo and Francesc Palau; J. Neurochem.(2013) 126 (Suppl. 1), 53–64. DOI: 10.1111/jnc.12303

FULL TEXT PDF